Skip to content

Hepatitis B Core Antibody, Immunoassay (Serum/Plasma)

Published: August 9, 2026Updated: August 16, 2026

This test detects antibodies to the hepatitis B core antigen, which can help identify past or current hepatitis B virus (HBV) infection.

Quick summary

["Helps diagnose or monitor hepatitis B infection by detecting immune system response to the virus."]

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
10673-2
Short code
HBV core Ag Tiss Ql ImStn
Synonyms
HBV core Ag Tiss Ql ImStn
Category
chemistry
Sample
serum
Container
Red-top tube (SST)
Units
N/A
Fasting
false
Population
adult
Sex
all
Age range
18–65 years
Method
immune-stain
Specimen volume
5 mL
Stability
Room temperature: 4h, Refrigerated: 24h, Frozen: 7d
Hemolysis max
500
Lipemia max
1000
Icterus max
500
TAT
4–24 hours
Order
routine

What This Test Measures

The test looks for **IgM antibodies** against the hepatitis B core antigen. IgM antibodies typically appear early in infection and can indicate an active HBV infection. This marker is less common after recovery or chronic infection.

Why It Matters in Diagnosis

Detecting IgM antibodies helps distinguish between acute HBV infection (new or recent exposure) and chronic infection. It’s often used alongside other tests like hepatitis B surface antigen (HBsAg) to confirm or rule out active viral replication.

Sample Collection and Preparation

A blood sample is drawn from a vein, usually in your arm. The blood is processed into serum or plasma for testing. This test is performed on the serum/plasma portion of the blood.

Common Uses and When to Test

Your healthcare provider may order this test if you have symptoms of hepatitis (e.g., fatigue, jaundice, abdominal pain), have risk factors for HBV (e.g., unprotected sex, travel to high-risk regions, tattoos/injections), or during routine screening (e.g., pregnant women, close contacts of infected individuals).

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

Positive IgM antibodies suggest an acute HBV infection, meaning the virus is actively replicating and may require medical evaluation or treatment. While IgM levels often decline after recovery, they can persist in some cases. Chronic HBV infection (long-term virus presence) is usually diagnosed with other markers like HBsAg and HBV DNA testing.

Short name

Hepatitis B Core Antibody (IgM)

Frequently asked questions

What Does a Positive Result Mean?
A positive result means your immune system has detected the hepatitis B core antigen, which could indicate recent or ongoing HBV infection. Follow-up testing (e.g., HBsAg, HBV DNA) will help determine the stage and next steps.
What If My Test Result Is Negative?
A negative result means no detectable IgM antibodies were found at this time, suggesting you either have never been infected or have recovered from HBV. However, repeated testing may be needed if you have risk factors for infection.
How Often Should I Get Retested?
If you have risk factors (e.g., travel, exposure history) or symptoms, your doctor may recommend retesting within 6–12 months. Chronic HBV carriers (positive HBsAg) are monitored regularly for disease progression.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy